Smart AFO and 5-Azacitidine to Enhance Mobility in Children With Cerebral Palsy
NCT: NCT07434492 · RECRUITING
Brief Summary
This is an intervention study to investigate the impact of a smart ankle-foot orthosis (AFO) on mobility outcomes in children with Cerebral Palsy. Participants will complete a three phase protocol including 6-weeks of at home training with the smart AFO. Participants will also have the option to participate in a randomized control trial to investigate the impact of 5-Azacitidine combined with the smart AFO to further effect mobility outcomes.
Frequently Asked Questions
What is Smart AFO and 5-Azacitidine to Enhance Mobility in Children With Cerebral Palsy?
Smart AFO and 5-Azacitidine to Enhance Mobility in Children With Cerebral Palsy is a clinical trial registered under NCT07434492. Current status: RECRUITING.
What is the status of NCT07434492?
The current status of NCT07434492 (Smart AFO and 5-Azacitidine to Enhance Mobility in Children With Cerebral Palsy) is: RECRUITING.
When did Smart AFO and 5-Azacitidine to Enhance Mobility in Children With Cerebral Palsy start?
Smart AFO and 5-Azacitidine to Enhance Mobility in Children With Cerebral Palsy started on 2026-05-28.
Official Source
View on ClinicalTrials.gov →Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.